STOCK TITAN

[144] The Carlyle Group Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

The Carlyle Group Inc. (CG) filed a Form 144 notifying a proposed sale of 97,394 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $6,074,882.57. The shares arise from issuer grants and vesting for services (performance stock units and restricted stock) dated 08/01/2025, 02/06/2025, 02/01/2025 and 08/01/2024, and those grant totals equal the amount the filer proposes to sell. The filing reports 361,704,907 shares outstanding, so the proposed sale represents approximately 0.027% of the outstanding common stock. The sale is expected to occur on or about 08/11/2025 on NASDAQ. The filer states no securities were sold in the past three months and attests to lacking any undisclosed material adverse information.

The Carlyle Group Inc. (CG) ha presentato un Modulo 144 per notificare la prevista vendita di 97,394 azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di $6,074,882.57. Le azioni derivano da attribuzioni dell'emittente e dal vesting legato a prestazioni (unità azionarie legate alla performance e azioni vincolate) datate 08/01/2025, 02/06/2025, 02/01/2025 e 08/01/2024; tali totali corrispondono all'ammontare che il dichiarante propone di vendere. Il deposito riporta 361,704,907 azioni in circolazione, quindi la vendita proposta rappresenta circa il 0.027% del capitale ordinario in circolazione. La vendita è prevista per il 08/11/2025 su NASDAQ. Il dichiarante dichiara che non sono stati venduti titoli negli ultimi tre mesi e attesta di non avere informazioni materiali sfavorevoli non divulgate.

The Carlyle Group Inc. (CG) presentó un Formulario 144 notificando la venta propuesta de 97,394 acciones ordinarias a través de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de $6,074,882.57. Las acciones provienen de concesiones del emisor y del vesting por servicios (performance stock units y restricted stock) fechadas 08/01/2025, 02/06/2025, 02/01/2025 y 08/01/2024, y esos totales de concesiones coinciden con la cantidad que el declarante propone vender. La presentación informa 361,704,907 acciones en circulación, por lo que la venta propuesta representa aproximadamente el 0.027% del capital social en circulación. Se espera que la venta ocurra en o alrededor del 08/11/2025 en NASDAQ. El declarante declara que no se vendieron valores en los últimos tres meses y afirma no tener información material adversa no divulgada.

The Carlyle Group Inc. (CG)는 Morgan Stanley Smith Barney LLC를 통해 총 시장가치가 $6,074,882.5797,394 보통주 매도를 신고하는 Form 144를 제출했습니다. 해당 주식은 발행인의 부여 및 서비스 제공에 따른 베스팅(성과 주식 단위 및 제한주식)으로, 날짜는 08/01/2025, 02/06/2025, 02/01/2025 및 08/01/2024이며 이러한 부여 합계는 신고인이 매각을 제안한 수량과 일치합니다. 신고서에는 361,704,907주의 유통주식수가 보고되어 제안된 매도는 약 0.027%의 보통주에 해당합니다. 매도는 NASDAQ에서 08/11/2025경에 이루어질 것으로 예상됩니다. 신고인은 지난 세 달 동안 매도된 증권이 없다고 밝히며 공개되지 않은 중대한 불리한 정보가 없음을 증언합니다.

The Carlyle Group Inc. (CG) a déposé un formulaire 144 notifiant la vente envisagée de 97,394 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour une valeur marchande totale de $6,074,882.57. Les actions proviennent d'attributions de l'émetteur et de l'acquisition liée à des prestations (performance stock units et restricted stock) datées du 08/01/2025, 02/06/2025, 02/01/2025 et 08/01/2024, et ces totaux d'attribution correspondent au montant que le déclarant propose de vendre. Le dépôt indique 361,704,907 actions en circulation ; la vente proposée représente donc environ 0.027% du capital ordinaire en circulation. La vente devrait avoir lieu aux alentours du 08/11/2025 sur le NASDAQ. Le déclarant précise que aucun titre n'a été vendu au cours des trois derniers mois et atteste ne détenir aucune information défavorable importante non divulguée.

The Carlyle Group Inc. (CG) hat ein Formular 144 eingereicht, das den geplanten Verkauf von 97,394 Stammaktien über Morgan Stanley Smith Barney LLC mit einem Gesamtmarktwert von $6,074,882.57 ankündigt. Die Aktien stammen aus Zuweisungen des Emittenten und dem Vesting für erbrachte Leistungen (Performance Stock Units und Restricted Stock) mit den Daten 08/01/2025, 02/06/2025, 02/01/2025 und 08/01/2024; diese Zuweisungssummen entsprechen der vom Melder vorgeschlagenen Verkaufsmenge. Die Einreichung gibt 361,704,907 ausstehende Aktien an, sodass der vorgeschlagene Verkauf etwa 0.027% des ausstehenden Stammkapitals ausmacht. Der Verkauf soll am oder um den 08/11/2025 an der NASDAQ erfolgen. Der Melder gibt an, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und versichert, keine nicht offengelegten wesentlichen nachteiligen Informationen zu besitzen.

Positive
  • Proposed sale equals vested compensation (performance stock units and restricted stock), showing the shares are tied to issuer-approved awards
  • Sale is immaterial to capitalization: 97,394 shares represent approximately 0.027% of the 361,704,907 shares outstanding
  • No sales reported in the past three months, indicating this is a discrete liquidity event rather than ongoing disposal
Negative
  • None.

Insights

TL;DR: Small, pre-arranged sale of vested awards; immaterial to market capitalization and unlikely to move the stock.

The filing describes a planned sale of 97,394 shares valued at $6.07M executed through Morgan Stanley Smith Barney on NASDAQ. The shares derive from performance stock units and restricted stock vesting granted by the issuer; the total granted equals the shares to be sold. With 361.7M shares outstanding, the sale equals roughly 0.027% of float, a de minimis proportion that suggests limited market impact. The filer reports no sales in the prior three months and makes the standard attestation regarding material nonpublic information. Overall, this is a routine insider liquidity event.

TL;DR: Insider selling vested compensation through a broker; disclosure and attestation are standard, raising no immediate governance red flags.

The transaction stems from compensation vesting and performance awards issued by the company and will be brokered by Morgan Stanley Smith Barney. The filing's disclosure that no sales occurred in the prior three months and the signer’s representation about material information are consistent with compliance expectations for Rule 144 notifications. Because the sale size is a very small fraction of outstanding shares, it does not indicate concentrated insider divestiture or governance concern based on the data provided.

The Carlyle Group Inc. (CG) ha presentato un Modulo 144 per notificare la prevista vendita di 97,394 azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di $6,074,882.57. Le azioni derivano da attribuzioni dell'emittente e dal vesting legato a prestazioni (unità azionarie legate alla performance e azioni vincolate) datate 08/01/2025, 02/06/2025, 02/01/2025 e 08/01/2024; tali totali corrispondono all'ammontare che il dichiarante propone di vendere. Il deposito riporta 361,704,907 azioni in circolazione, quindi la vendita proposta rappresenta circa il 0.027% del capitale ordinario in circolazione. La vendita è prevista per il 08/11/2025 su NASDAQ. Il dichiarante dichiara che non sono stati venduti titoli negli ultimi tre mesi e attesta di non avere informazioni materiali sfavorevoli non divulgate.

The Carlyle Group Inc. (CG) presentó un Formulario 144 notificando la venta propuesta de 97,394 acciones ordinarias a través de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de $6,074,882.57. Las acciones provienen de concesiones del emisor y del vesting por servicios (performance stock units y restricted stock) fechadas 08/01/2025, 02/06/2025, 02/01/2025 y 08/01/2024, y esos totales de concesiones coinciden con la cantidad que el declarante propone vender. La presentación informa 361,704,907 acciones en circulación, por lo que la venta propuesta representa aproximadamente el 0.027% del capital social en circulación. Se espera que la venta ocurra en o alrededor del 08/11/2025 en NASDAQ. El declarante declara que no se vendieron valores en los últimos tres meses y afirma no tener información material adversa no divulgada.

The Carlyle Group Inc. (CG)는 Morgan Stanley Smith Barney LLC를 통해 총 시장가치가 $6,074,882.5797,394 보통주 매도를 신고하는 Form 144를 제출했습니다. 해당 주식은 발행인의 부여 및 서비스 제공에 따른 베스팅(성과 주식 단위 및 제한주식)으로, 날짜는 08/01/2025, 02/06/2025, 02/01/2025 및 08/01/2024이며 이러한 부여 합계는 신고인이 매각을 제안한 수량과 일치합니다. 신고서에는 361,704,907주의 유통주식수가 보고되어 제안된 매도는 약 0.027%의 보통주에 해당합니다. 매도는 NASDAQ에서 08/11/2025경에 이루어질 것으로 예상됩니다. 신고인은 지난 세 달 동안 매도된 증권이 없다고 밝히며 공개되지 않은 중대한 불리한 정보가 없음을 증언합니다.

The Carlyle Group Inc. (CG) a déposé un formulaire 144 notifiant la vente envisagée de 97,394 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour une valeur marchande totale de $6,074,882.57. Les actions proviennent d'attributions de l'émetteur et de l'acquisition liée à des prestations (performance stock units et restricted stock) datées du 08/01/2025, 02/06/2025, 02/01/2025 et 08/01/2024, et ces totaux d'attribution correspondent au montant que le déclarant propose de vendre. Le dépôt indique 361,704,907 actions en circulation ; la vente proposée représente donc environ 0.027% du capital ordinaire en circulation. La vente devrait avoir lieu aux alentours du 08/11/2025 sur le NASDAQ. Le déclarant précise que aucun titre n'a été vendu au cours des trois derniers mois et atteste ne détenir aucune information défavorable importante non divulguée.

The Carlyle Group Inc. (CG) hat ein Formular 144 eingereicht, das den geplanten Verkauf von 97,394 Stammaktien über Morgan Stanley Smith Barney LLC mit einem Gesamtmarktwert von $6,074,882.57 ankündigt. Die Aktien stammen aus Zuweisungen des Emittenten und dem Vesting für erbrachte Leistungen (Performance Stock Units und Restricted Stock) mit den Daten 08/01/2025, 02/06/2025, 02/01/2025 und 08/01/2024; diese Zuweisungssummen entsprechen der vom Melder vorgeschlagenen Verkaufsmenge. Die Einreichung gibt 361,704,907 ausstehende Aktien an, sodass der vorgeschlagene Verkauf etwa 0.027% des ausstehenden Stammkapitals ausmacht. Der Verkauf soll am oder um den 08/11/2025 an der NASDAQ erfolgen. Der Melder gibt an, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und versichert, keine nicht offengelegten wesentlichen nachteiligen Informationen zu besitzen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Carlyle Group's (CG) Form 144 report?

The filing notifies a proposed sale of 97,394 common shares valued at $6,074,882.57 to be executed via Morgan Stanley Smith Barney on NASDAQ around 08/11/2025.

How were the shares being sold acquired?

The shares were acquired from the issuer as performance stock units and restricted stock vesting on 08/01/2025, 02/06/2025, 02/01/2025 and 08/01/2024.

What percentage of Carlyle's outstanding stock does the proposed sale represent?

The filing shows 361,704,907 shares outstanding, so the proposed sale of 97,394 shares equals about 0.027% of outstanding stock.

Were any securities sold by this person in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

Does the filer attest to possession of material nonpublic information?

Yes, the filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.
The Carlyle Group Inc.

NASDAQ:CG

CG Rankings

CG Latest News

CG Latest SEC Filings

CG Stock Data

22.58B
265.88M
26.34%
63.75%
3.12%
Asset Management
Investment Advice
Link
United States
WASHINGTON